ACTiF- Assessment of Closed Tibial Fractures

PHASE2CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Tibial Fractures
Interventions
DRUG

CP-533, 536

Active study drug

DRUG

Placebo

Placebo vehicle

PROCEDURE

Standard of Care

Standard surgical procedure

DRUG

CP-533,536

Active study drug

DRUG

CP-533,536

Active study drug

DRUG

CP-533,536

Active study drug

Trial Locations (56)

2013

Pfizer Investigational Site, Soweto

2193

Pfizer Investigational Site, Parktown

4000

Pfizer Investigational Site, Glenwood

4029

Pfizer Investigational Site, Herston

5000

Pfizer Investigational Site, Adelaide

7505

Pfizer Investigational Site, Tygerberg

10000

Pfizer Investigational Site, Zagreb

26505

Pfizer Investigational Site, Morgantown

26506

Pfizer Investigational Site, Morgantown

27710

Pfizer Investigational Site, Durham

34098

Pfizer Investigational Site, Istanbul

35100

Pfizer Investigational Site, Izmir

37403

Pfizer Investigational Site, Chattanooga

41013

Pfizer Investigational Site, Seville

42000

Pfizer Investigational Site, Varaždin

55415

Pfizer Investigational Site, Minneapolis

65212

Pfizer Investigational Site, Columbia

67214

Pfizer Investigational Site, Wichita

71000

Pfizer Investigational Site, Sarajevo

75246

Pfizer Investigational Site, Dallas

77030

Pfizer Investigational Site, Houston

84108

Pfizer Investigational Site, Salt Lake City

141008

Pfizer Investigational Site, Ludhiana

193312

Pfizer Investigational Site, Saint Petersburg

195427

Pfizer Investigational Site, Saint Petersburg

226003

Pfizer Investigational Site, Lucknow

01655

Pfizer Investigational Site, Worcester

T4N 4E7

Pfizer Investigational Site, Red Deer

T4N 6V7

Pfizer Investigational Site, Red Deer

L8L 2X2

Pfizer Investigational Site, Hamilton

N6A 4G5

Pfizer Investigational Site, London

N6A 5W9

Pfizer Investigational Site, London

K1Y 4E9

Pfizer Investigational Site, Ottawa

N7T 4P3

Pfizer Investigational Site, Sarnia

N7T 4R9

Pfizer Investigational Site, Sarnia

N7T 6H3

Pfizer Investigational Site, Sarnia

N7T 6H5

Pfizer Investigational Site, Sarnia

N7T 6H6

Pfizer Investigational Site, Sarnia

N7T 6S3

Pfizer Investigational Site, Sarnia

N7T G6G

Pfizer Investigational Site, Sarnia

M5B 1W8

Pfizer Investigational Site, Toronto

500 003

Pfizer Investigational Site, Secunderabad

560 001

Pfizer Investigational Site, Bangalore

560 034

Pfizer Investigational Site, Bangalore

575 001

Pfizer Investigational Site, Mangalore

400 012

Pfizer Investigational Site, Mumbai

Unknown

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Kitakyushu-shi

Pfizer Investigational Site, Mizumaki-cho Onga-gun

Pfizer Investigational Site, Okawa-shi

Pfizer Investigational Site, Fujisawa-shi

Pfizer Investigational Site, Kouchi

Pfizer Investigational Site, Sasebo-Shi

Pfizer Investigational Site, Toda-shi

Pfizer Investigational Site, Shinagawa-ku

06100

Pfizer Investigational Site, Ankara

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00533377 - ACTiF- Assessment of Closed Tibial Fractures | Biotech Hunter | Biotech Hunter